Quality of life in patients with multiple sclerosis

Acta Clinica Croatica

Volumn 52, Issue 1, 2013, Pages 107-112

  Kes, Vanja Bašić ^a   Čengić, Ljiljana ^a   Cesarik, Marijan ^a   Tomas, Ana Jadrijević ^a   Zavoreo, Iris ^a   Matovina, Lucija Zadro ^a   Ćorić, Lejla ^a   Drnasin, Sara ^a   Demarin, Vida ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Multiple sclerosis quality of life; Multiple sclerosis therapy

Indexed keywords

COMPARATIVE STUDY; DEPRESSION; FAMILY LIFE; FATIGUE; FATIGUE IMPACT SCALE; FATIGUE SEVERITY SCALE; FOLLOW UP; HAMILTON SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; QUALITY OF LIFE; REVIEW; SELF CONCEPT; SHORT FORM 36; SICKNESS IMPACT PROFILE; SOCIAL STATUS; SOCIAL SUPPORT; WELLBEING;

ATAXIA; CHRONIC PAIN; COGNITION DISORDERS; DEPRESSION; DISABILITY EVALUATION; DISEASE PROGRESSION; FATIGUE; HUMANS; IRRITABLE BOWEL SYNDROME; MOOD DISORDERS; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; MUSCLE WEAKNESS; QUALITY OF LIFE; QUESTIONNAIRES; TREMOR; URINARY BLADDER, NEUROGENIC; VERTIGO; VISION DISORDERS;

EID: 84888804327     PISSN: 03539466     EISSN: 13339451     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Ve'cseie L, Milanov I. The epi demiology of multiple sclerosis in Europe. Eur J Neurol 2006;13:700-22.
2. Koutsouraki E, Costa V, Baloyannis S. Epi demiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 2010;22:2-13.
3. Trapp BD, Peterson J, Ransohoff RM, et al. Ax-onal transaction in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85.
4. Compston A, Coles A. Multiple sclerosis. Lancet 2008;25;372(9648):1502-17.
5. Motl RW, Mcauley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-ef ficacy and social support. Psychol Health Med 200914:111-24.
6. Benito-Leon J, Morales JM, Rivera-Navar-Ro J, Mitchell AJ. A review about the impact of mul tiple sclerosis on health-related quality of life. Disabil Rehabil 2003;25:1291-303.
7. Mitchell AJ, Benito-Leon J, Gonzalez JMM, Rivera-NavArro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of well-being. Lancet Neurology 2005;4:556-66.
8. Bošnjak-Pašić M, Vidrih B, Miškov S, De-Marin V. Treatment of multiple sclerosis. Acta Clin Croat 2009;48:349-53.
9. Goldman MD, Cohen JA, Fox RJ, Bethoux FA. Multiple sclerosis: treating symptoms and other general medical issues. Cleve Clin J Med 2006;73:177-86.
10. Ben-Zacharia AB. Therapeutics for multiple sclerosis symptoms. Mt Sinai J Med 2011;78:176-91.
11. Burks JS, Bigley Gk, Hill HH. Rehabilitation challenges in multiple sclerosis. Ann Indian Acad Neurol 2009;12:296-306.
12. Yadav V, Shinto L, Bourdette D. Complemen tary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol 2010;6:381-95.
13. Olascoaga J. Quality of life and multiple sclerosis. Rev Neurol 2010;51:279-88.
14. The WHOQOL group. Development of the WHOQoL - BREF quality of life assessment. Psychol Med 1998;28: 551-8.
15. Bussing A, Matthiessen PF, Ostermann T. Engagement of patients in religious and spiritual practices: confirmatory results with the SpREUK-P 1.1 questionnaire as a tool of quality of life research. Health Qual Life Out comes 2005;3:53.
16. Al-Tahan AM, Al-Jumah MA, Bohlega SM, et al. The importance of quality-of-life assessment in the manage ment of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory group. Neurosciences (Riyadh) 2011;16:109-13.
17. Centers for Disease Control and Prevention. Measuring healthy days: population assessment of health-related qual ity of life. Atlanta, georgia: Centers for Disease Control and Prevention, 2000.
18. Gandek B, Sinclair SJ, Kosinski M, Ware JE Jr. Psychometric evaluation of the SF-36 health survey in Medi care managed care. Health Care Financ Rev 2004;25:5-25.
19. Balcer LJ. Clinical outcome measures for research in multiple sclerosis. J Neuroophthalmol 2001;21:296-301.
20. Opara J, Jaracz K, Brola W. Current possibilities of assessment of quality of life in multiple sclerosis. Neurol Neurochir Pol 2006;4:336-41.
21. Bandari DS, Vollmer TL, Khatri BO, Tyry T. Assessing quality of life in patients with multiple sclerosis. Int JMSCare2010;12:34-41.
22. Opara J, Jaracz K, Brola W. Quality of life in stroke patients. J Med Life 2010;3:352-8.
23. Fischer JS, Larocca NG, Miller DM, et al. Recent development of quality of life in multiple sclerosis (MS). Mult Scler 1999;5:251-9.
24. EuroQoL group. EuroQoL: a new facility for the mea surement of health-related quality of life. Health Policy 1990;16:199-208.
25. Mchorney AC, Ware JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
26. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revi sion of a health status measure. Med Care 1981;19:787-805.
27. Carlsson M, Hamrin E, Lindqvist R. Psycho metric assessment of the Life Satisfaction Questionnaire (LSQ) and a comparison of a randomised sample of Swedish women and those suffering from breast cancer. Qual Life Res 1999;3:245-53.
28. The WHOQoL group. The World Health Organization Quality of Life assessment (WHOQoL): Position paper from the World Health Organization. Soc Sci Med 1995;41:1403.
29. Kaplan RM, Atkins CJ, Timms R. Validity of a qual ity of well-being scale as an outcome measure in chronic ob structive pulmonary disease. J Chronic Dis 1984;37:85-95.
30. Vickrey BG, Hays RD, Genovese BJ, et al. Com parison of a generic to disease-targeted health-related qual ity-of-life measures for multiple sclerosis. J Clin Epidemiol 1997;50:557-69.
31. Cella DF, Dineen K, Arnason B, et al. Validation of the functional assessment of multiple sclerosis quality of life instruments. Neurology 1996;47:129-39.
32. Lobentanz IS, Asenbaum S, Vass K, etal. Factors influencing quality of life in multiple sclerosis patients: dis ability, depressive mood, fatigue and sleep quality. Acta Neu rol Scand2004;110:6-13.
33. Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 2003,17:225-34.
34. Minden SL, Schiffer RB. Affective disorders in mul tiple sclerosis. Review and recommendations for clinical re search. Arch Neurol 1990;54:531-3.
35. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch gen Psychiatry 1961;4:561-71.
36. Hedlund JL, Viewig BW. The Hamilton Rating Scale for Depression: a comprehensive review. J Oper Psychiatry 1979;10:149-65.
37. Moran PJ, Mohr DC. The Validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med 2005.35-41, DOI:10.1007/s 100865-005-2561-0
38. Zigmond A, Snaith RP. The hospital anxiety and de pression scale. Acta Psych Scand 1983;67:361-70.
39. Bombardier CH, Wadhwani R, Larotondaa C. Health promotion in people with multiple sclerosis. Phys Med Rehabil Clin North Am 2005;16:557-70.
40. Kargiotis O, Paschalli A, Messinis L, Papa-Thanasopoulos P. Quality of life in multiple sclero sis: effects of current treatment options. Int Rev Psychiatry 2010;22:67-82.
41. Baumstarck-Barrau K, Pelletier J, Simeoni MC, et al. French validation of the Multiple Sclerosis Inter national Quality of Life Questionnaire. Rev Neurol (Paris) 2011;167(6-7):511-21.